Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series-Reference-Cited by-同舟云学术

Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series

Published:2019-06-02 Issue:18 Volume:125 Page:3234-3241
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kambhampati Swetha¹²^ORCID,Bauer Kelly E.²,Bracci Paige M.³,Keenan Bridget P.¹²,Behr Spencer C.⁴,Gordan John D.¹²⁵,Kelley Robin K.¹²^ORCID

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine University of California at San Francisco Medical Center San Francisco California

2. Division of Hematology and Oncology, Department of MedicineUniversity of California at San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco California

3. Department of Epidemiology and Biostatistics University of California at San Francisco San Francisco California

4. Department of Radiology University of California at San Francisco Medical Center San Francisco California

5. Quantitative Biosciences Institute University of California at San Francisco San Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32206

Reference40 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer